<DOC>
	<DOCNO>NCT02624778</DOCNO>
	<brief_summary>The study evaluate effect LY3002813 brain scan . The study evaluate safety LY3002813 look adverse event ( side effect ) . The study also look effect body LY3002813 . Study participant mild cognitive impairment ( MCI ) due AD mild moderate AD . The study involve 3 part . - Part A participant receive single dose LY3002813 placebo ( drug ) . - Part B participant receive multiple dos LY3002813 placebo 24 week . - Part C participant receive multiple dos LY3002813 placebo 72 week . Drug give injection vein . For Parts A , B C , study last approximately 72 week , include screen approximately 42 day . The study research purpose intend treat medical condition .</brief_summary>
	<brief_title>A Study LY3002813 Participants With Memory Damage Due Alzheimer 's Disease ( AD ) AD</brief_title>
	<detailed_description />
	<mesh_term>Alzheimer Disease</mesh_term>
	<criteria>Present mild cognitive impairment ( MCI ) due Alzheimer 's disease ( AD ) mildtomoderate AD Men nonfertile woman , least 50 year age . Nonfertile define hysterectomy and/or bilateral oophorectomy , amenorrhea least 1 year Have caregiver/study informant provide separate write informed consent participate Have adequate vision hear neuropsychological test opinion investigator Positive florbetapir scan Do reliable caregiver/study informant frequent contact participant , accompany participant office and/or available telephone designate time , monitor administration prescribe medication Are monitor radiation due occupational exposure ionize radiation , exposure ionize radiation within last 12 month investigational study History intracranial hemorrhage , cerebrovascular aneurysm arteriovenous malformation , carotid artery occlusion , stroke epilepsy Have contraindication magnetic resonance imaging ( MRI ) study , include claustrophobia , presence contraindicate metal ( ferromagnetic ) implant , cardiac pacemaker Have allergy humanize monoclonal antibody , include protein diphenhydramine , epinephrine , methylprednisolone Have gamma globulin therapy within last year Previously dose study investigate active immunization amyloid beta ( Aβ ) Previously dose study investigate passive immunization Aβ within last 6 month Have current serious unstable illness</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>